Published: Nov 15, 2018
Focus:
Insights
As the Northern Powerhouse Investment Fund (NPIF) celebrates backing £100m of investment across the Northern Powerhouse region, BQ looks back at some of the businesses that are achieving their ambitious growth plans with our support.
Manchester-based Microbiosensor secured a £700,000 equity investment from NPIF Maven Equity Finance, in a co-investment deal alongside Catapult Cheshire Life Sciences Fund.
Established in 2012, the University of Manchester spin-out company develops disposable point-of-care medical devices for the early diagnosis of microbial infection. The funding has allowed the company to complete the development of its first product, TripleCheck, an infection diagnostic for patients on renal dialysis, and to plan for a multicentre clinical study to validate that product in Q2 2019.
To view the full article on BQ click here.
The Northern Powerhouse Investment Fund project is supported financially by the European Union using funding from the European Regional Development Fund (ERDF) as part of the European Structural and Investment Funds Growth Programme 2014-2020 and the European Investment Bank.
